Literature DB >> 32020294

Effects of enhanced depth imaging and en face averaging on optical coherence tomography angiography image quantification.

Keke Liu1,2, Nihaal Mehta1,3, A Yasin Alibhai1, Malvika Arya1, Osama Sorour1,4, Akihiro Ishibazawa1,5, Iksoo Byon6,7, Caroline R Baumal1,8, Andre J Witkin1,8, Jay S Duker1,8, SriniVas R Sadda6,7, Nadia K Waheed9,10.   

Abstract

PURPOSE: To examine the effects of enhanced depth imaging (EDI) and en face averaging on global vascular measurements of optical coherence tomography angiography (OCTA) images.
METHODS: All eyes were imaged with 3 mm × 3 mm fields centered at the fovea using the Carl Zeiss Cirrus 5000 spectral-domain OCTA, with and without EDI, and the Zeiss PLEX Elite 9000 swept-source OCTA. Vessel area density (VAD), vessel length (VL), and vessel diameter index (VDI) were calculated for the superficial capillary plexus (SCP) en face angiograms. For the choriocapillaris (CC), VAD and the number, total area, and average size of flow voids were calculated. These metrics were compared between SD- and SS-OCTA images, with and without en face averaging and EDI.
RESULTS: Both averaging and EDI had a significant effect on quantitative metrics. EDI images trended toward a decrease in SCP VAD. In the CC, EDI decreased average flow void size. Averaging increased CC VAD while decreasing number of flow voids, total flow void area, and average flow void size. With both averaging and EDI, SD-OCTA was not able to visualize as many CC flow voids, particularly of a smaller size, compared with SS-OCTA.
CONCLUSIONS: Averaging and EDI affect quantitative metrics from SCP and CC OCTA images. EDI resulted in a trend toward decreased VAD in SCP images. Averaging had a major effect on CC imaging. Even with the combination of EDI and en face averaging, SD-OCTA images do not appear to approximate SS-OCTA images in terms of quantitative metrics. This has implications for clinical and research use of SD-OCTA for retinal imaging.

Keywords:  Enhanced depth imaging; Optical coherence tomography angiography; Retinal imaging

Year:  2020        PMID: 32020294     DOI: 10.1007/s00417-020-04610-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Enhanced depth imaging spectral-domain optical coherence tomography.

Authors:  Richard F Spaide; Hideki Koizumi; Maria C Pozzoni; Maria C Pozonni
Journal:  Am J Ophthalmol       Date:  2008-07-17       Impact factor: 5.258

2.  Impact of Multiple En Face Image Averaging on Quantitative Assessment from Optical Coherence Tomography Angiography Images.

Authors:  Akihito Uji; Siva Balasubramanian; Jianqin Lei; Elmira Baghdasaryan; Mayss Al-Sheikh; SriniVas R Sadda
Journal:  Ophthalmology       Date:  2017-03-17       Impact factor: 12.079

3.  Choriocapillaris degeneration and related pathologic changes in human diabetic eyes.

Authors:  J Cao; S McLeod; C A Merges; G A Lutty
Journal:  Arch Ophthalmol       Date:  1998-05

4.  Choriocapillaris Flow Features Follow a Power Law Distribution: Implications for Characterization and Mechanisms of Disease Progression.

Authors:  Richard F Spaide
Journal:  Am J Ophthalmol       Date:  2016-08-02       Impact factor: 5.258

5.  Image Averaging, a Powerful Tool in Optical Coherence Tomography and Optical Coherence Tomography Angiography.

Authors:  Nadia K Waheed; Jay S Duker
Journal:  JAMA Ophthalmol       Date:  2017-11-01       Impact factor: 7.389

6.  Enhanced optical coherence tomography imaging by multiple scan averaging.

Authors:  B Sander; M Larsen; L Thrane; J L Hougaard; T M Jørgensen
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

Review 7.  Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration.

Authors:  G Lutty; J Grunwald; A B Majji; M Uyama; S Yoneya
Journal:  Mol Vis       Date:  1999-11-03       Impact factor: 2.367

8.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

9.  Spectral-domain optical coherence tomography with multiple B-scan averaging for enhanced imaging of retinal diseases.

Authors:  Atsushi Sakamoto; Masanori Hangai; Nagahisa Yoshimura
Journal:  Ophthalmology       Date:  2007-12-03       Impact factor: 12.079

10.  Determinants of Quantitative Optical Coherence Tomography Angiography Metrics in Patients with Diabetes.

Authors:  Fang Yao Tang; Danny S Ng; Alexander Lam; Fiona Luk; Raymond Wong; Carmen Chan; Shaheeda Mohamed; Angie Fong; Jerry Lok; Tiffany Tso; Frank Lai; Marten Brelen; Tien Y Wong; Clement C Tham; Carol Y Cheung
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

View more
  4 in total

1.  Optical coherence tomography angiography for quantitative microvascular assessment in diabetic retinopathy: inter-device and intra-device agreement and correlation with clinical staging.

Authors:  Emanuele Crincoli; Donato Colantuono; Zhanlin Zhao; Eric H Souied; Alexandra Miere
Journal:  Acta Diabetol       Date:  2022-07-05       Impact factor: 4.087

2.  Clinical Utility of Triplicate En Face Image Averaging for Optical Coherence Tomography Angiography in Glaucoma and Glaucoma Suspects.

Authors:  Andrew J Nelson; Zhongdi Chu; Bruce Burkemper; Brenda R Chang; Benjamin Xu; Ruikang K Wang; Grace M Richter
Journal:  J Glaucoma       Date:  2020-09       Impact factor: 2.290

Review 3.  Towards standardizing retinal optical coherence tomography angiography: a review.

Authors:  Danuta M Sampson; Adam M Dubis; Fred K Chen; Robert J Zawadzki; David D Sampson
Journal:  Light Sci Appl       Date:  2022-03-18       Impact factor: 17.782

4.  Choriocapillaris flow deficit in a pachychoroid spectrum disease using en face optical coherence tomography angiography averaging.

Authors:  Miho Tagawa; Sotaro Ooto; Kenji Yamashiro; Hiroshi Tamura; Akio Oishi; Akihito Uji; Manabu Miyata; Masahiro Miyake; Ayako Takahashi; Ai Ichioka; Akitaka Tsujikawa
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.